Propanc Health (PPCH) 0.0375 $PPCH The NASDAQ Biotech

New Post Public Reply Private Reply Replies (0) Message Board

Sep 11, 2015 at 10:40 PM

Propanc Health (PPCH) 0.0375 $PPCH

The NASDAQ Biotech Index Is Partying Like It's 1999 - Some Say The Party's Just Getting Started, Some Say We're At The Top
ACCESSWIRE - Mon Aug 24, 4:10PM CDT
WINDSOR, ON / ACCESSWIRE / August 24, 2015 / The Wealthy Biotech Trader (or "WBT"

, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, would like to discuss some recent explosions in share price of two biotech stocks and two biotech Company's which have pending news which could serve as catalysts to potentially move their stocks.
IYH: 150.96 (+1.16), SPY: 196.74 (+0.89), AQXP: 17.26 (+0.80), ANTH: 8.03 (-0.15), ONCS: 6.33 (+0.21)

Propanc Identifies Potential Patent Opportunities
ACCESSWIRE - Thu Aug 13, 8:58AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / August 13, 2015 / Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic and colorectal cancers, today announced that the Company has identified potential patent opportunities as a result of the ongoing research and development activities underway with its research partners.

Propanc Up-lists to OTCQB; Reduces Authorized Shares by 80%
ACCESSWIRE - Tue Aug 04, 7:30AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / August 4, 2015 / Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic and colorectal cancers, today announced the Company recently commenced trading on the OTCQB Marketplace, and confirms it continues to file periodic reports under Section 15(d) of the Exchange Act.

Propanc Identifies Positive Signals for Efficacy from Pilot Animal Studies
ACCESSWIRE - Thu Jul 09, 8:46AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / July 9, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that positive signals have emerged in several pilot animal studies measuring the effects of PRP against several tumor types.

Propanc Enters into Research Agreement with Adaptive Biotechnologies
ACCESSWIRE - Mon Jul 06, 11:40AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / July 6, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that it has entered into a biomarker discovery agreement with Adaptive Biotechnologies, Seattle, WA, USA.

The Wealthy Biotech Trader's New Feature Pick Runs Over 150% After Announcement - Traders are Calling it the Next PPCH 3,200%+ Runner
ACCESSWIRE - Thu Jun 25, 10:42AM CDT
WINDSOR, ON / ACCESSWIRE / June 25, 2015 / The Wealthy Biotech Trader (or "WBT"

, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves, would like to report on the recent move PositiveID (OTC: PSID) has made in the market. WBT reiterates PositiveID (OTC: PSID) as their pick for the summer and into the fall.
ADXS: 16.51 (+0.55)

Penny Stocks Alerts for TOTALLY HEMP CRAZY, TapImmune, Root9b Technologies, EKSO BIONICS HOLDING, Propanc Health Group, and Dominovas Energy
PR Newswire - Thu Jun 25, 7:49AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: TOTALLY HEMP CRAZY (OTCMKTS:THCZ), TapImmune (OTCMKTS:TPIV), Root9b Technologies (OTCMKTS:RTNB), EKSO BIONICS HOLDING (OTCBB:EKSO), Propanc Health Group (OTCMKTS

PCH), and Dominovas Energy (OTCMKTS

NRG).

Propanc Provides Shareholder Update
ACCESSWIRE - Fri Jun 19, 7:52AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / June 19, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced a summary of Corporate and R&D activities currently underway as part of a shareholder update since presenting at the SeeThru Equity Conference last month.

Penny Stocks Recap for Propanc Health Group, Arrayit Corp, PositiveID, TapImmune, TOTALLY HEMP CRAZY, and Medican Enterprises
PR Newswire - Fri Jun 19, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Propanc Health Group (OTCMKTS

PCH), Arrayit Corp (OTCMKTS:ARYC), PositiveID (OTCMKTS

SID), TapImmune (OTCMKTS:TPIV), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), and Medican Enterprises (OTCMKTS:MDCN).

Propanc Settles Two Outstanding Convertible Debts
ACCESSWIRE - Thu Jun 18, 7:31AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / June 18, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company repaid two outstanding convertible notes as part of its plans to reduce overall debt.

Three Companies with the Ingredients to Follow in the Footsteps of Advaxis (NASDAQ: ADXS)
ACCESSWIRE - Tue Jun 16, 2:34PM CDT
WINDSOR, ON / ACCESSWIRE / June 16, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves, would like to report on the seldom huge potential of the OTC market when used as a proper stepping-stone to a national stock exchange.
ADXS: 16.51 (+0.55)

Penny Stocks Research for Hangover Joe's, Terra Tech, TOTALLY HEMP CRAZY, Medican Enterprises, Propanc Health Group, and MaryJane Group
PR Newswire - Thu Jun 11, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Hangover Joe's (OTCMKTS:HJOE), Terra Tech (OTCMKTS:TRTC), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), Medican Enterprises (OTCMKTS:MDCN), Propanc Health Group (OTCMKTS

PCH), and MaryJane Group (OTCMKTS:MJMJ).

Propanc Briefs Investors at the SeeThruEquity 4th Annual Investor Conference
ACCESSWIRE - Fri May 29, 10:47AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 29, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company briefed investors at the SeeThruEquity 4th Annual Microcap Investor Conference, held at the Convene Grand Central, Midtown Manhattan, New York, on Thursday, May 28th.

SeeThruEquity Initiates Coverage on Propanc Health Group with a Price Target of $1.52
ACCESSWIRE - Wed May 27, 9:12AM CDT
NEW YORK, NY / ACCESSWIRE / May 27, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Propanc Health Group Corp.. (PINKSHEETS: PPCH) with a Price Target of $1.52.

Corrected Article - The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer
ACCESSWIRE - Tue May 19, 4:00PM CDT
WINDSOR, ON / ACCESSWIRE / May 19, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves.
VSTM: 6.06 (-0.09), CERU: 4.70 (-0.18), PPHM: 1.17 (-0.02)

The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer
ACCESSWIRE - Sun May 17, 2:43PM CDT
WINDSOR, ON / ACCESSWIRE / May 17, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves.
VSTM: 6.06 (-0.09), CERU: 4.70 (-0.18), PPHM: 1.17 (-0.02)

Propanc Engages Maxim Group LLC as Strategic Advisors
ACCESSWIRE - Wed May 13, 5:01AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 13, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, announced today that it has retained Maxim Group LLC, a leading investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting Propanc in its strategies for maximizing shareholder value through its full scope of investment banking services, including pursuing a listing of the Company's common stock on a nationally recognized exchange.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

DAR Logs Massive 587,000 Service Hours Nationwide

A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...

Landis+Gyr's Q2 Gains and Future Strategies

Landis+Gyr's Multi-Faceted Financial Leap In the unpredictable landscape of energy tech, Landis+Gyr has thrown down some noteworthy cards in their latest financial disclosures. We're talking a Q2 net revenue sitting pretty at $269.2 million, and it's no mistake they landed a record-smashing adjusted gross margin of 38.0%. All this while wrangling an order intake of $170.3...

Casio's CMK?100: A Lightweight Marvel Blending Style and Utility

A Timepiece That Redefines Everyday Elegance There's a new player in the vast realm of watches, and it's got tongues wagging: the Casio CMK?100. You don’t see that blend of style, comfort, and practicality grow on trees, my friend. Casio’s new offering, the CMK?100, wears its purpose on its titanium sleeve: lightweight and stylish, it’s a suave addition to any wrist...

Yale's $10M Inflammation Initiative: Future Health Impact

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

MPLX Adds Industry Veterans to Board Leadership

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

From Missouri to Market: A New Spin on Turkey Calls

Innovating the Turkey Call Game You want innovation? Well, wrap your head around this: a Missouri inventor is flipping the script on turkey mouth calls. The goal? To ditch the wrinkles and make turkey hunting that much smoother. It might seem a bit niche, but when you've been around long enough, you know these 'niche' ideas can sometimes hatch golden eggs for investors....

Bechtel's $1M Push for Wyoming's Skilled Trades Future

Wyoming's Bid for Skilled Trades Revolution You’d think with all the talk about tech and white-collar jobs, we’ve forgotten the backbone that keeps the world ticking—skilled trades. Turns out, Bechtel hasn’t. The company just tossed a cool million at Wyoming's Laramie County Community College and Western Wyoming College. What’s that doing? It's jumpstarting...

Trump Quotation Book Takes Unbiased Approach

In the ever-evolving dance of political discourse, a new book strides onto the stage: Not My President, published by Palmetto Publishing. It’s a bold compilation of presidential utterances, capturing the words of Donald J. Trump in all their unvarnished glory. Stripped of analysis or comedic flair, each entry stands alone like a solitary figure at a cocktail party,...